Stay updated on Pembrolizumab and Olaparib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Olaparib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Olaparib in NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The website has been updated to version v2.11.0, with new results submitted, while the previous version v2.10.5 has been removed along with a notice about delays in study record information.
    Difference
    4%
    Check dated 2024-09-25T22:30:27.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    ClinicalTrials.gov is addressing delays in displaying study record information, and the site has been updated to version 2.10.5, replacing the previous version 2.10.3.
    Difference
    4%
    Check dated 2024-09-18T16:39:55.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The website has been updated from version v2.10.2 to v2.10.3.
    Difference
    0.3%
    Check dated 2024-09-04T05:04:32.000Z thumbnail image
  5. Check
    35 days ago
    No Change Detected
  6. Check
    49 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.3%
    Check dated 2024-08-13T23:27:10.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The website has added new functionality for viewing and comparing study record versions in the latest update (v2.10.0), replacing the previous version (v2.9.7).
    Difference
    6%
    Check dated 2024-07-23T14:42:28.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.3%
    Check dated 2024-07-16T06:40:34.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Olaparib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Olaparib in NSCLC Clinical Trial page.